Indication
Flaviviridae infections
2 clinical trials
3 products
Clinical trial
VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and AdolescentsStatus: Completed, Estimated PCD: 2019-10-04
Product
VRC-ZKADNA090-00-VPClinical trial
A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-5172 + MK-3682 + MK-8408 Fixed Dose Combination (FDC)) in Subjects With Chronic HCV GT1 or GT3 Infection Who Have Failed a Direct Acting Antiviral RegimenStatus: Terminated, Estimated PCD: 2017-01-09
Product
MK-3682BProduct
Ribavirin